Pay in 4 interest-free payments of $29.38 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
decrease the phosphorylation of mitogen-activated protein kinases (MAPKs)
InChi: InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H
which is a concentration that has little or no adverse effect on the host cell (cell viability >80%)
and Sirtuin2
14b-icosahydropicene-4a-carboxylic acid
GV-58 60427 decrease the phosphorylation of mitogen-activatedGV 58 is a potent, selective N and P Q type Ca2+ channels agonist with EC50 of 7. 21 8. 81 uM for N type P Q type Ca2+ channel; 20 fold less potent CDK inhibitor activity. IC50 value: 7. 21 8. 81 uM (N type P Q type Ca2+ channel) Target: Ca2+ channel agonistIn comparison with the parent molecule, (R) roscovitine, GV 58 has a 20 fold less potent cyclin dependent kinase antagonist effect, a 3 to 4 fold more potent Ca2+ channel agonist effect, and 4 fold